Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Details) - Schedule of warrant activities

v3.22.1
Shareholders' Deficit (Details) - Schedule of warrant activities - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Shareholders' Deficit (Details) - Schedule of warrant activities [Line Items]    
Number of Warrants, Balance Outstanding, Beginning 8,445,698 2,050,000
Weighted Average Exercise Price, Balance Outstanding, Beginning $ 0.4 $ 0.1
Number of Warrants, Exercised  
Number of Warrants, Balance Outstanding, Ending   8,445,698
Weighted Average Exercise Price, Balance Outstanding, Ending   $ 0.4
Aggregate Intrinsic Value, Balance Outstanding, Ending  
Warrant [Member]    
Shareholders' Deficit (Details) - Schedule of warrant activities [Line Items]    
Number of Warrants, Balance Outstanding, Beginning 2,050,000  
Weighted Average Exercise Price, Balance Outstanding, Beginning $ 0.05  
Number of Warrants, Exercised (1,050,000) 288,750
Weighted Average Exercise Price, Exercised $ (0.01) $ 0.1
Aggregate Intrinsic Value, Exercised  
Number of Warrants, Cancelled   (288,750)
Weighted Average Exercise Price, Cancelled   $ (0.1)
Number of Warrants, Balance Outstanding, Ending 17,500,000 2,050,000
Weighted Average Exercise Price, Balance Outstanding, Ending $ 0.05 $ 0.05
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 4 years 8 months 1 day 3 years 7 months 28 days
Aggregate Intrinsic Value, Balance Outstanding, Ending $ 137,000
Number of Warrants, Exercisable 17,500,000  
Weighted Average Exercise Price, Exercisable $ 0.05  
Weighted Average Remaining Contractual Term (Years), Exercisable 4 years 8 months 1 day  
Aggregate Intrinsic Value, Exercisable  
Number of Warrants, Granted 16,500,000  
Weighted Average Exercise Price, Granted $ 0.05  
Aggregate Intrinsic Value, Granted